• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of FDA advisory committee meetings during the month, that were identified as needing a Patient Representative, that had a Patient Representative (1)

Dictionary: Patient Representatives participate in advisory committee meetings to ensure patient input on important medical product review and policy questions.

The Patient Representative’s role is to provide the advisory committee and FDA insight on issues, problems, and/or questions pertinent to the unique viewpoint of patients living with a specific disease.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetPercent
Oct 201180100
Nov 20118089
Dec 20118086
Jan 20128067
Feb 201280100
Mar 201280100
Apr 201280100

FY 2012 Oct-Apr Overall: 93%

Footnotes

  • (1) This measure will no longer be tracked after April 2012.

Number of FDA advisory committee meetings during the month that had a Patient Representative (1)

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A3
Nov 2011N/A8
Dec 2011N/A6
Jan 2012N/A2
Feb 2012N/A8
Mar 2012N/A6
Apr 2012N/A5

FY 2012 Oct-Apr Total: 38

Number of FDA advisory committee meetings during the month, that were identified as needing a Patient Representative, that had a Patient Representative (1)

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A3
Nov 2011N/A9
Dec 2011N/A7
Jan 2012N/A3
Feb 2012N/A8
Mar 2012N/A6
Apr 2012N/A5

FY 2012 Oct-Apr Total: 41

Total number of advisory committee meetings during the month (1)

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/A4
Nov 2011N/A9
Dec 2011N/A7
Jan 2012N/A3
Feb 2012N/A10
Mar 2012N/A6
Apr 2012N/A5

FY 2012 Oct-Apr Total: 44

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.